182 related articles for article (PubMed ID: 36291575)
1. Prostate Cancer-Associated miRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool.
Luedemann C; Reinersmann JL; Klinger C; Degener S; Dreger NM; Roth S; Kaufmann M; Savelsbergh A
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291575
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
Jin W; Fei X; Wang X; Chen F; Song Y
J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
[TBL] [Abstract][Full Text] [Related]
3. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
4. Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
Kang HW; Byun YJ; Moon SM; Kim K; Piao XM; Zheng CM; Moon SK; Choi YH; Kim WT; Kim YJ; Lee SC; Yun SJ; Kim WJ
Investig Clin Urol; 2022 Mar; 63(2):238-244. PubMed ID: 35244999
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
6. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
Kim J; Shim JS; Han BH; Kim HJ; Park J; Cho IJ; Kang SG; Kang JY; Bong KW; Choi N
Biosens Bioelectron; 2021 Nov; 192():113504. PubMed ID: 34298498
[TBL] [Abstract][Full Text] [Related]
7. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.
Juracek J; Madrzyk M; Trachtova K; Ruckova M; Bohosova J; Barth DA; Pichler M; Stanik M; Slaby O
Cancer Genomics Proteomics; 2023; 20(3):308-316. PubMed ID: 37093688
[TBL] [Abstract][Full Text] [Related]
8. Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition.
Porzycki P; Ciszkowicz E; Semik M; Tyrka M
Int Urol Nephrol; 2018 Sep; 50(9):1619-1626. PubMed ID: 30014459
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Level of Circulating hsa-miR-297 and hsa-miR-19b-3p miRNA Are Associated with Generalization of Prostate Cancer.
Osip'yants AI; Knyazev EN; Galatenko AV; Nyushko KM; Galatenko VV; Shkurnikov MY; Alekseev BY
Bull Exp Biol Med; 2017 Jan; 162(3):379-382. PubMed ID: 28091918
[TBL] [Abstract][Full Text] [Related]
10. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population.
Lyu J; Zhao L; Wang F; Ji J; Cao Z; Xu H; Shi X; Zhu Y; Zhang C; Guo F; Yang B; Sun Y
Biomed Res Int; 2019; 2019():9306803. PubMed ID: 31534967
[TBL] [Abstract][Full Text] [Related]
12. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
13. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
14. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
Roberts MJ; Chow CW; Schirra HJ; Richards R; Buck M; Selth LA; Doi SA; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
Prostate; 2015 Apr; 75(5):539-49. PubMed ID: 25597828
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.
Wang H; Yang L; Mi Y; Wang Y; Ma C; Zhao J; Liu P; Gao Y; Li P
Contrast Media Mol Imaging; 2022; 2022():6094409. PubMed ID: 35935308
[TBL] [Abstract][Full Text] [Related]
17. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of miR-494 in Serum of Patients with Prostate Cancer and its Potential Diagnostic Value.
Cai B; Peng JH
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414754
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNAs 21 and 221 as biomarkers for early diagnosis of prostate cancer.
Kotb S; Mosharafa A; Essawi M; Hassan H; Meshref A; Morsy A
Tumour Biol; 2014 Dec; 35(12):12613-7. PubMed ID: 25190021
[TBL] [Abstract][Full Text] [Related]
20. The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3p.
Tölle A; Jung K; Friedersdorff F; Maxeiner A; Lein M; Fendler A; Stephan C
Cancer Biomark; 2021; 30(4):381-393. PubMed ID: 33361585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
